Recent evidence regarding triclosan and cancer risk

International Journal of Environmental Research and Public Health

Volumn 11, Issue 2, 2014, Pages 2209-2217

  Dinwiddie, Michael T ^a   Terry, Paul D ^a,b   Chen, Jiangang ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

Breast neoplasms; Cancer; Epidemiologic studies; Fatty acid synthesis; Triclosan; Xenoestrogens

Indexed keywords

FATTY ACID; POLYCHLORINATED BIPHENYL; TRICLOSAN; TOPICAL ANTIINFECTIVE AGENT;

CANCER; EPIDEMIOLOGY; ESTROGENIC COMPOUND; FATTY ACID; HEALTH IMPACT; HEALTH RISK;

ARTICLE; CANCER RISK; CARCINOGENESIS; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); DISEASE ACTIVITY; DRUG EXPOSURE; FATTY ACID SYNTHESIS; HUMAN; IN VITRO STUDY; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR PATHOLOGY; NONHUMAN; PATIENT ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; SOCIAL ASPECT; CHEMICALLY INDUCED; NEOPLASM; RISK; TOXICITY;

ANTI-INFECTIVE AGENTS, LOCAL; HUMANS; NEOPLASMS; RISK; TRICLOSAN;

EID: 84894289392     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph110202209     Document Type: Article

References (32)

1. Roy, J.R.; Chakraborty, S.; Chakraborty, T.R. Estrogen-like endocrine disrupting chemicals affecting puberty in humans-A review. Med. Sci. Monit. 2009, 15, RA137-145.
2. Fernandez, S.V.; Russo, J. Estrogen and xenoestrogens in breast cancer. Toxicol. Pathol. 2010, 38, 110-122.
3. Erler, C.; Novak, J. Bisphenol a exposure: Human risk and health policy. J. Pediatr. Nurs. 2010, 25, 400-407.
4. Darbre, P.D. Environmental oestrogens, cosmetics and breast cancer. Best Pract. Res. Clin. Endocrinol. Metab. 2006, 20, 121-143.
5. Bhargava, H.N.; Leonard, P.A. Triclosan: Applications and safety. Am. J. Infect. Control 1996, 24, 209-218.
6. Dann, A.B.; Hontela, A. Triclosan: Environmental exposure, toxicity and mechanisms of action. J. Appl. Toxicol. 2011, 31, 285-311.
7. Sandborgh-Englund, G.; Adolfsson-Erici, M.; Odham, G.; Ekstrand, J. Pharmacokinetics of triclosan following oral ingestion in humans. J. Toxicol. Environ. health. Part A 2006, 69, 1861-1873.
8. Moss, T.; Howes, D.; Williams, F.M. Percutaneous penetration and dermal metabolism of triclosan (2,4,4'-trichloro-2'-hydroxydiphenyl ether). Food Chem. Toxicol. 2000, 38, 361-370.
9. Allmyr, M.; Harden, F.; Toms, L.M.; Mueller, J.F.; McLachlan, M.S.; Adolfsson-Erici, M.; Sandborgh-Englund, G. The influence of age and gender on triclosan concentrations in Australian human blood serum. Sci. Total Environ. 2008, 393, 162-167.
10. Adolfsson-Erici, M.; Pettersson, M.; Parkkonen, J.; Sturve, J. Triclosan, a commonly used bactericide found in human milk and in the aquatic environment in Sweden. Chemosphere 2002, 46, 1485-1489.
11. Calafat, A.M.; Ye, X.; Wong, L.Y.; Reidy, J.A.; Needham, L.L. Urinary concentrations of triclosan in the U.S. Population: 2003-2004. Environ. Health Perspect. 2008, 116, 303-307.
12. Allmyr, M.; Adolfsson-Erici, M.; McLachlan, M.S.; Sandborgh-Englund, G. Triclosan in plasma and milk from swedish nursing mothers and their exposure via personal care products. Sci. TotalEnviron. 2006, 372, 87-93.
13. Dayan, A.D. Risk assessment of triclosan [irgasan] in human breast milk. Food Chem. Toxicol. 2007, 45, 125-129.
14. Bedoux, G.; Roig, B.; Thomas, O.; Dupont, V.; Le Bot, B. Occurrence and toxicity of antimicrobial triclosan and by-products in the environment. Environ. Sci. Pollut. Res. Int. 2012, 19, 1044-1065.
15. Rodricks, J.V.; Swenberg, J.A.; Borzelleca, J.F.; Maronpot, R.R.; Shipp, A.M. Triclosan: A critical review of the experimental data and development of margins of safety for consumer products. Crit. Rev. Toxicol. 2010, 40, 422-484.
16. Laas, E.; Poilroux, C.; Bezu, C.; Coutant, C.; Uzan, S.; Rouzier, R.; Chereau, E. Antibacterialcoated suture in reducing surgical site infection in breast surgery: A prospective study. Int. J. Breast Cancer 2012, 2012, 819578.
17. Toms, L.M.; Allmyr, M.; Mueller, J.F.; Adolfsson-Erici, M.; McLachlan, M.; Murby, J.; Harden, F.A. Triclosan in individual human milk samples from australia. Chemosphere 2011, 85, 1682-1686.
18. Geens, T.; Neels, H.; Covaci, A. Distribution of bisphenol-a, triclosan and n-nonylphenol in human adipose tissue, liver and brain. Chemosphere 2012, 87, 796-802.
19. Calafat, A.M.; Ye, X.; Silva, M.J.; Kuklenyik, Z.; Needham, L.L. Human exposure assessment to environmental chemicals using biomonitoring. Int. J. Androl. 2006, 29, 166-171.
20. Calafat, A.M.; M., K.H.; Swan, S.H.; Hauser, R.; Goldman, L.R.; Lanphear, B.P.; Longnecker, M.P.; Rudel, R.A.; Teitelbaum, S.L.; Whyatt, R.M.; Wolff, M.S. Misuse of blood serum to assess exposure to bisphenol a and phthalates. Breast Cancer Res. 2013, 15, 403.
21. Ahn, K.C.; Zhao, B.; Chen, J.; Cherednichenko, G.; Sanmarti, E.; Denison, M.S.; Lasley, B.; Pessah, I.N.; Kultz, D.; Chang, D.P.; Gee, S.J.; Hammock, B.D. In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: Receptor-based bioassay screens. Environ. Health Perspect. 2008, 116, 1203-1210.
22. Gee, R.H.; Charles, A.; Taylor, N.; Darbre, P.D. Oestrogenic and androgenic activity of triclosan in breast cancer cells. J. Appl. Toxicol. 2008, 28, 78-91.
23. Henry, N.D.; Fair, P.A. Comparison of in vitro cytotoxicity, estrogenicity and anti-estrogenicity of triclosan, perfluorooctane sulfonate and perfluorooctanoic acid. J. appl. Toxicol. 2013, 33, 265-272.
24. Stoker, T.E.; Gibson, E.K.; Zorrilla, L.M. Triclosan exposure modulates estrogen-dependent responses in the female wistar rat. Toxicol. Sci. 2010, 117, 45-53.
25. Recchia, A.G.; Vivacqua, A.; Gabriele, S.; Carpino, A.; Fasanella, G.; Rago, V.; Bonofiglio, D.; Maggiolini, M. Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha. Food add. Contam. 2004, 21, 134-144.
26. Liu, B.; Wang, Y.; Fillgrove, K.L.; Anderson, V.E. Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to mcf-7 and skbr-3 breast cancer cells. CancerChemother Pharm. 2002, 49, 187-193.
27. Deepa, P.R.; Vandhana, S.; Muthukumaran, S.; Umashankar, V.; Jayanthi, U.; Krishnakumar, S. Chemical inhibition of fatty acid synthase: Molecular docking analysis and biochemical validation in ocular cancer cells. J. Ocul. Boil. Dis. Informa. 2010, 3, 117-128.
28. Deepa, P.R.; Vandhana, S.; Jayanthi, U.; Krishnakumar, S. Therapeutic and toxicologic evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells. Basic Clin. Pharm. Toxicol. 2012, 110, 494-503.
29. Vandhana, S.; Coral, K.; Jayanthi, U.; Deepa, P.R.; Krishnakumar, S. Biochemical changes accompanying apoptotic cell death in retinoblastoma cancer cells treated with lipogenic enzyme inhibitors. Biochimica et Biophysica Acta 2013, 1831, 1458-1466.
30. Lu, S.; Archer, M.C. Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer. Carcinogenesis 2005, 26, 153-157.
31. Kuhajda, F.P. Fatty-acid synthase and human cancer: New perspectives on its role in tumor biology. Nutrition 2000, 16, 202-208.
32. Flavin, R.; Peluso, S.; Nguyen, P.L.; Loda, M. Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol. 2010, 6, 551-562.